GRB7 and cancer: Of note, the detailed regulatory mechanisms, side effects, proper dose, tolerability, as well as treatment-induced resistant cancers against molecules targeting Grb7 or in combination with protein tyrosine kinase-targeting agents/drugs remains to be evaluated.